Abstract
Introduction Adiponectin (APO) and proinsulin (P-INS) are commonly used biomarkers in patients with metabolic diseases such as diabetes mellitus (DM) and metabolic syndrome. Both markers have intensively been investigated for their role in metabolic disorders. The liver plays an important part during the pathogenesis of different metabolic diseases like i.e., nonalcoholic
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Diabetes Research and Clinical Metabolism
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
